Vitamin D deficiency in oncology patients - an ignored condition: Impact on Hypocalcemia and quality of life

Israel Medical Association Journal

Volumn 14, Issue 10, 2012, Pages 607-612

  Segal, Elena ^a,d   Felder, Shira ^e   Haim, Nissim ^b,d   Yoffe Sheinman, Hedva ^b   Peer, Avivit ^b   Wollner, Mira ^b   Shen Or, Zila ^c   Ish Shalom, Sophia ^a,d  

^a Metabolic Bone Diseases Unit   (Israel)

^b Technion Israel Institute of Technology ^*  (Israel)

^c Endocrine Laboratory   (Israel)

^d TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^e SHEBA MEDICAL CENTER   (Israel)

Author keywords

Bisphosphonates; Hypocalcemia; Oncology patients; Quality of life; Vitamin D

Indexed keywords

ALBUMIN; CALCITRIOL; CALCIUM; CALCIUM CARBONATE; CARBOXY TERMINAL TELOPEPTIDE; CREATININE; LIVER ENZYME; PAMIDRONIC ACID; PARATHYROID HORMONE; PROCOLLAGEN C PROTEINASE; TRASTUZUMAB; VITAMIN D; ZOLEDRONIC ACID;

ADULT; AGED; ARTICLE; BONE METASTASIS; CANCER PATIENT; COMORBIDITY; CROSS-SECTIONAL STUDY; FEMALE; FOLLOW UP; FOOD INTAKE; HUMAN; HYPOCALCEMIA; MAJOR CLINICAL STUDY; MALE; NEOPLASM; QUALITY OF LIFE; QUESTIONNAIRE; SKIN COLOR; SUN EXPOSURE; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

ADULT; AGED; AGED, 80 AND OVER; BONE NEOPLASMS; CALCIUM; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPOCALCEMIA; INCIDENCE; ISRAEL; MALE; MIDDLE AGED; QUALITY OF LIFE; RETROSPECTIVE STUDIES; RISK FACTORS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84868228858     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Barni S, Mandala M, Cazzaniga M, Cremonesi M. Bisphosphonates and metastatic bone disease. Ann Oncol 2006; 17 (Suppl 2): ii91-5.
2. Morgan G, Lipton A. Antitumor effects and anticancer applications of bisphosphonates. Semin Oncol 2010; 37 (Suppl 2): S30-40.
3. Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982; 5: 649-55.
4. Favus MJ, Goltzman D. Regulation of calcium and magnesium. In: Rosen CJ, ed. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 7th edn. Washington: American Society of Bone and Mineral Research, 2008; Chap 21: 104-8.
5. Sato Y, Tamaki J, Kitayama F, Kusaka Y, Kodera Y, Koutani A, Iki M. Development of a food-frequency questionnaire to measure the dietary calcium intake of adult Japanese women. Tohoku J Exp Med 2005; 207: 217-22.
6. Hettiaratchy S, Papini R. Initial management of a major burn: II. Assessment and resuscitation. BMJ 2004; 329: 101-3.
7. Aapro M, Abrahamsson PA, Body JJ, et al. Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel. Ann Oncol 2008; 19: 420-32.
8. Hypponen E, Power C. Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors. Am J Clin Nutr 2007; 85: 860-8.
9. Holick MF, Siris ES, Binkley N, et al. Prevalence of Vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab 2005; 90: 3215-24.
10. Ng K, Sargent DJ, Goldberg RM, et al. Vitamin D status in patients with stage IV colorectal cancer: findings from Intergroup trial N9741. J Clin Oncol 2011; 29: 1599-606.
11. Abbas S, Linseisen J, Slanger T, et al. Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer-results of a large case-control study. Carcinogenesis 2008; 29: 93-9.
12. Chlebowski RT, Johnson KC, Kooperberg C, et al. Calcium plus vitamin D supplementation and the risk of breast cancer. J Natl Cancer Inst 2008; 100: 1581-91.
13. Vieth R, Fraser D. Vitamin D insufficiency: no recommended dietary allowance exists for this nutrient. CMAJ 2002; 166: 1541-2.
14. Dietary Reference Intakes for Calcium and Vitamin D. Institute of Medicine Report. Washington DC: The National Academies Press, 2011.
15. Heaney RP. Vitamin D and calcium interactions: functional outcomes. Am J Clin Nutr 2008; 88: 541-4S.
16. Thomas MK, Lloyd-Jones DM, Thadhani RI, et al. Hypovitaminosis D in medical inpatients. N Engl J Med 1998; 338: 777-83.
17. Chapuy MC, Preziosi P, Maamer M, et al. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int 1997; 7: 439-43.
18. Garnero P, Hausherr E, Chapuy MC, et al. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study. J Bone Miner Res 1996; 11: 1531-8.
19. Bischoff-Ferrari HA, Dietrich T, Orav EJ, et al. Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged > or =60 y. Am J Clin Nutr 2004; 80: 752-8.
20. Stewart R, Hirani V. Relationship between Vitamin D levels and depressive symptoms in older residents from a national survey population. Psychosom Med 2010; 72: 608-12.
21. Drake MT, Maurer MJ, Link BK, et al. Vitamin D insufficiency and prognosis in non-Hodgkin's lymphoma. J Clin Oncol 2010; 28: 4191-8.
22. Goodwin PJ. Vitamin D in cancer patients: above all, do no harm. J Clin Oncol 2009; 27: 2117-19.
23. Tanvetyanon T, Stiff PJ. Management of the adverse effects associated with intravenous bisphosphonates. Ann Oncol 2006; 17: 897-907.